← FDA Drug Approvals (Drugs@FDA)

ANDA214440

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2022-01-14

Drug application

FDA Application #

ANDA214440

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

GLENMARK PHARMS LTD

First approval

2022-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown